全文获取类型
收费全文 | 35724篇 |
免费 | 2194篇 |
国内免费 | 160篇 |
专业分类
耳鼻咽喉 | 508篇 |
儿科学 | 834篇 |
妇产科学 | 642篇 |
基础医学 | 4248篇 |
口腔科学 | 658篇 |
临床医学 | 3466篇 |
内科学 | 8498篇 |
皮肤病学 | 412篇 |
神经病学 | 3362篇 |
特种医学 | 1435篇 |
外国民族医学 | 1篇 |
外科学 | 6243篇 |
综合类 | 223篇 |
一般理论 | 18篇 |
预防医学 | 2117篇 |
眼科学 | 491篇 |
药学 | 2053篇 |
中国医学 | 45篇 |
肿瘤学 | 2824篇 |
出版年
2024年 | 26篇 |
2023年 | 207篇 |
2022年 | 396篇 |
2021年 | 893篇 |
2020年 | 545篇 |
2019年 | 890篇 |
2018年 | 1091篇 |
2017年 | 752篇 |
2016年 | 773篇 |
2015年 | 927篇 |
2014年 | 1365篇 |
2013年 | 1839篇 |
2012年 | 2703篇 |
2011年 | 2901篇 |
2010年 | 1648篇 |
2009年 | 1586篇 |
2008年 | 2500篇 |
2007年 | 2645篇 |
2006年 | 2455篇 |
2005年 | 2372篇 |
2004年 | 2147篇 |
2003年 | 2009篇 |
2002年 | 1804篇 |
2001年 | 277篇 |
2000年 | 184篇 |
1999年 | 247篇 |
1998年 | 395篇 |
1997年 | 311篇 |
1996年 | 227篇 |
1995年 | 224篇 |
1994年 | 183篇 |
1993年 | 177篇 |
1992年 | 103篇 |
1991年 | 112篇 |
1990年 | 94篇 |
1989年 | 82篇 |
1988年 | 65篇 |
1987年 | 63篇 |
1986年 | 67篇 |
1985年 | 72篇 |
1984年 | 91篇 |
1983年 | 90篇 |
1982年 | 85篇 |
1981年 | 81篇 |
1980年 | 67篇 |
1979年 | 40篇 |
1978年 | 40篇 |
1977年 | 27篇 |
1975年 | 27篇 |
1974年 | 28篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
991.
Refaat MM Tanaka T Kormos RL McNamara D Teuteberg J Winowich S London B Simon MA 《Journal of cardiac failure》2012,18(2):140-145
BackgroundImplantable cardioverter-defibrillators (ICDs) reduce mortality in heart failure (HF). In patients requiring a ventricular assist device (VAD), the benefit from ICD therapy is not well established. The aim of this study was to define the impact of ICD on outcomes in VAD-supported patients.Methods and ResultsWe reviewed data for consecutive adult HF patients receiving VAD as a bridge to transplantation from 1996 to 2003. The primary outcome was survival to transplantation. A total of 144 VADs were implanted [85 left ventricular (LVAD), 59 biventricular (BIVAD), mean age 50 ± 12 years, 77% male, left ventricular ejection fraction 18 ± 9%, 54% ischemic]. Mean length of support was 119 days (range 1–670); 103 patients (72%) survived to transplantation. Forty-five patients had an ICD (33 LVAD, 12 BIVAD). More LVAD patients had an appropriate ICD shock before implantation than after (16 vs 7; P = .02). There was a trend toward higher shock frequency before LVAD implant than after (3.3 ± 5.2 vs 1.1 ± 3.8 shocks/y; P = .06). Mean time to first shock after VAD implant was 129 ± 109 days. LVAD-supported patients with an ICD were significantly more likely to survive to transplantation [1-y actuarial survival to transplantation: LVAD: 91% with ICD vs 57% without ICD (log-rank P = .01); BIVAD: 54% vs 47% (log-rank P = NS)]. An ICD was associated with significantly increased survival in a multivariate model controlling for confounding variables (odds ratio 2.54, 95% confidence interval 1.04–6.21; P = .04).ConclusionsShock frequency decreases after VAD implantation, likely owing to ventricular unloading, but appropriate ICD shocks still occur in 21% of patients. An ICD is associated with improved survival in LVAD-supported HF patients. 相似文献
992.
993.
Sokol H Beaugerie L Maynadié M Laharie D Dupas JL Flourié B Lerebours E Peyrin-Biroulet L Allez M Simon T Carrat F Brousse N;for the CESAME Study Group 《Inflammatory bowel diseases》2012,18(11):2063-2071
BACKGROUND: It remains to be shown whether inflammatory bowel disease (IBD) is associated with an increased risk of primary intestinal lymphoproliferative disorders (PILD). We assessed this risk in the CESAME French nationwide prospective observational cohort. METHODS: In all, 680 gastroenterologists enrolled 19,486 patients with IBD (Crohn's disease in 60.3%) from May 2004 to June 2005. Follow-up ended on 31 December 2007. Available biopsy samples and surgical specimens from patients with PILD (n = 14) were centralized for review. The reference incidence of PILD in the general population was obtained from the C?te d'Or registry and was used as a comparator to assess the standardized incidence ratio (SIR). The influence of thiopurine exposure was explored in a nested case-control study. RESULTS: In the CESAME population the crude incidence of PILD was 0.12/1000 patient-years, with a corresponding SIR of 17.51 (95% confidence interval [CI], 6.43-38.11; P < 0.0001). The risk was highest in patients exposed to thiopurines (SIR 49.52, 95% CI 13.49-126.8; P < 0.0001), while it did not reach statistical significance in patients na?ve to thiopurines (SIR 4.83, 95% CI, 0.12-26.91; P = 0.37). The odds ratio associated with ongoing thiopurine exposure (vs. na?ve) was 2.97 (95% CI, 0.30-infinity; P = 0.38). All 14 cases of PILD were non-Hodgkin's B-cell LD, 78.6% occurred in males, 85.7% arose in IBD lesions, and 45.5% were Epstein-Barr virus-positive. Eleven cases occurred in patients with Crohn's disease. Mean (SD) age at PILD diagnosis was 55.1 (5.6) years and the median time since IBD onset was 8.0 years (interquartile range, 3.0-15.8). CONCLUSIONS: Patients with IBD have an increased risk of developing PILD. (Inflamm Bowel Dis 2012;). 相似文献
994.
995.
Seegers J Vos MA Flevari P Willems R Sohns C Vollmann D Lüthje L Kremastinos DT Floré V Meine M Tuinenburg A Myles RC Simon D Brockm?ller J Friede T Hasenfu? G Lehnart SE Zabel M;EUTrigTreat Clinical Study Investigators 《Europace : European pacing, arrhythmias, and cardiac electrophysiology》2012,14(3):416-422
996.
997.
998.
999.
1000.
Dipeptidyl peptidase IV inhibition improves cardiorenal function in overpacing-induced heart failure